Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 vs LL-37: Research Application Comparison

Tendon/Ligament Repair Models Superior. Increases collagen synthesis, VEGF expression, and tensile strength by 60–85% vs controls No direct effect. Antimicrobial action irrelevant to connective tissue regeneration BPC-157 Multiple controlled animal studies (J

This comparison does not assign a generated winner or score.

  • Tendon/Ligament Repair Models
  • Superior. Increases collagen synthesis, VEGF expression, and tensile strength by 60–85% vs controls
  • No direct effect. Antimicrobial action irrelevant to connective tissue regeneration
  • BPC-157
  • Multiple controlled animal studies (J Physiol Pharmacol 2020)
  • Bacterial Wound Infection Models
  • No antimicrobial activity. Cannot reduce bacterial load
  • Superior. Reduces bacterial CFU by 70–90% within 24 hours via membrane disruption
  • LL-37
  • In vitro and in vivo antimicrobial assays (J Immunol 2017)
  • Gastric Ulcer Healing (Rodent Models)
  • Superior. Accelerates epithelial closure and reduces inflammation markers by 55–70%
  • No documented efficacy in gastric healing. Not studied for this application
  • Controlled trials in rats (Eur J Pharmacol 2019)
  • Immune Modulation Research
  • Indirect effect via NO pathway modulation. Not a primary mechanism
  • Direct effect. Activates FPRL1 receptors, recruits neutrophils/monocytes, modulates cytokine release
  • Receptor binding and chemotaxis studies (Front Immunol 2021)
  • Bone Healing/Fracture Models
  • Moderate. Enhances angiogenesis around fracture sites, improving healing by 30–40%
  • No direct bone regeneration effect. Antimicrobial role in preventing infection post-surgery
  • BPC-157 for healing; LL-37 for infection prophylaxis
  • Rodent fracture studies (Bone 2018)
  • Storage Stability for Long-Term Protocols
  • Excellent. Stable at room temp for 90 days lyophilized; 28 days reconstituted at 2–8°C
  • Poor. Requires −20°C storage lyophilized; reconstituted aliquots lose 15% potency/week
  • BPC-157 for protocols requiring multiple doses over weeks
  • Peptide stability assays (vendor technical data)
More references

Related material